TMCnet News
Cystic Fibrosis Market 2015-2022 - Global Strategic Business Report 2017 - FDA Approves Vertex's ORKAMBI - Research and MarketsResearch and Markets has announced the addition of the "Cystic Fibrosis - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Cystic Fibrosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2022. Market data and analytics are derived from primary and secondary research. The report profiles 56 companies, including many key and niche players such as:
1. Market Overview 2. Research In Cystic Fibrosis Space 3. Disease Overview 4. Cystic Fibrosis Treatment: An Overview 5. Clinical Studies 6. Product Launches/Approvals 7. Recent Industry Activity 8. Select Clinical-Stage Players 9. Focus On Select Global Players 10. Global Market Perspective Total Companies Profiled: 56 (including Divisions/Subsidiaries 58) - The United States (30) - Canada (4) - Europe (20) - France (2) - Germany (2) - The United Kingdom (3) - Italy (2) - Rest of Europe (11) - Asia-Pacific (Excluding Japan) (1) - Middle East (3) For more information about this report visit http://www.researchandmarkets.com/research/nzbg59/cystic_fibrosis.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170320006184/en/ |
